{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T03:51:00Z","timestamp":1789271460994,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.jinf.2015.03.013","type":"journal-article","created":{"date-parts":[[2015,5,2]],"date-time":"2015-05-02T18:21:21Z","timestamp":1430590881000},"page":"200-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Dramatic reduction of clindamycin serum concentration in staphylococcal osteoarticular infection patients treated with the oral clindamycin-rifampicin combination"],"prefix":"10.1016","volume":"71","author":[{"given":"Aur\u00e9lie","family":"Bernard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gw\u00e9nol\u00e9","family":"Kermarrec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perrine","family":"Parize","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Caruba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Bouvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Mainardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Sabatier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Nich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jinf.2015.03.013_bib1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijantimicag.2011.04.023","article-title":"In\u00a0vitro pharmacokinetic\/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates","volume":"38","author":"Vidaillac","year":"2011","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"10.1016\/j.jinf.2015.03.013_bib2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijid.2004.09.009","article-title":"Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials?","volume":"9","author":"Lazzarini","year":"2005","journal-title":"Int J Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2015.03.013_bib3","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/clinids\/4.6.1133","article-title":"Clindamycin: a review of fifteen years of experience","volume":"4","author":"Dhawan","year":"1982","journal-title":"Rev Infect Dis"},{"issue":"S1","key":"10.1016\/j.jinf.2015.03.013_bib4","first-page":"S152","article-title":"Oral antibiotic therapy","volume":"32","author":"O'Toole","year":"2014","journal-title":"J Orthop Res"},{"issue":"1","key":"10.1016\/j.jinf.2015.03.013_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/CMR.00034-09","article-title":"Rifampin combination therapy for nonmycobacterial infections","volume":"23","author":"Forrest","year":"2010","journal-title":"Clin Microbiol Rev"},{"issue":"21","key":"10.1016\/j.jinf.2015.03.013_bib6","doi-asserted-by":"crossref","first-page":"12208","DOI":"10.1073\/pnas.95.21.12208","article-title":"Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction","volume":"95","author":"Bertilsson","year":"1998","journal-title":"Proc Natl Acad Sci U. S. A"},{"issue":"6","key":"10.1016\/j.jinf.2015.03.013_bib7","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1365-2125.2012.04292.x","article-title":"Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis","volume":"74","author":"Bouazza","year":"2012","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.jinf.2015.03.013_bib8","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/archinte.168.8.805","article-title":"Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: a systematic review of the literature","volume":"168","author":"Perlroth","year":"2008","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.jinf.2015.03.013_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0732-8893(86)90147-1","article-title":"In\u00a0vitro evaluation of clindamycin in combination with oxacillin, rifampin, or vancomycin against Staphylococcus aureus","volume":"4","author":"Ho","year":"1986","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2015.03.013_bib10","author":"European Committee on Antimicrobial Susceptibility Testing"},{"issue":"1","key":"10.1016\/j.jinf.2015.03.013_bib11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1128\/AAC.01081-09","article-title":"Continuous clindamycin infusion, an innovative approach to treating bone and joint infections","volume":"54","author":"Zeller","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.jinf.2015.03.013_bib12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0002-9343(87)90688-7","article-title":"Multicenter collaborative evaluation of standardized serum bactericidal test as a predictor of therapeutic efficacy in acute and chronic osteomyelitis","volume":"83","author":"Weinstein","year":"1987","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.jinf.2015.03.013_bib13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/jac\/31.4.581","article-title":"Tissue penetration of clindamycin in diabetic foot infections","volume":"31","author":"Duckworth","year":"1993","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.jinf.2015.03.013_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antimicrobial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2015.03.013_bib15","series-title":"Antibiotics in laboratory medicine","first-page":"230","article-title":"Measurement of antibiotics in human body fluids: techniques and significance","author":"Klassen","year":"1996"},{"key":"10.1016\/j.jinf.2015.03.013_bib16","series-title":"Clinical antimicrobial assays","author":"Reeves","year":"1999"},{"issue":"2","key":"10.1016\/j.jinf.2015.03.013_bib17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/AAC.33.2.245","article-title":"In\u00a0vitro interaction between rifampin and clindamycin against pathogenic coagulase-negative staphylococci","volume":"33","author":"Arditi","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.jinf.2015.03.013_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0163-4453(93)95367-R","article-title":"Interactions of drugs acting against Staphylococcus aureus in\u00a0vitro and in a mouse model","volume":"26","author":"Renneberg","year":"1993","journal-title":"J Infect"},{"issue":"5","key":"10.1016\/j.jinf.2015.03.013_bib19","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10096-010-0902-6","article-title":"In\u00a0vitro antimicrobial synergy testing of coagulase-negative staphylococci isolated from prosthetic joint infections using Etest and with a focus on rifampicin and linezolid","volume":"29","author":"Hellmark","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2015.03.013_bib20","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1128\/AAC.29.4.611","article-title":"Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus","volume":"29","author":"Hackbarth","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.jinf.2015.03.013_bib21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.medmal.2008.06.030","article-title":"Treatment of osteoarticular infections with clindamycin in adults","volume":"38","author":"Samad El","year":"2008","journal-title":"Med Mal Infect"},{"issue":"4","key":"10.1016\/j.jinf.2015.03.013_bib22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.medmal.2009.12.009","article-title":"Recommendations for bone and joint prosthetic device infections in clinical practice (prosthesis, implants, osteosynthesis). Soci\u00e9t\u00e9 de Pathologie Infectieuse de Langue Fran\u00e7aise","volume":"40","author":"Soci\u00e9t\u00e9 de Pathologie Infectieuse de Langue Fran\u00e7aise (SPILF)","year":"2010","journal-title":"Med Mal Infect"},{"issue":"6","key":"10.1016\/j.jinf.2015.03.013_bib23","doi-asserted-by":"crossref","first-page":"pp.1046","DOI":"10.1302\/0301-620X.81B6.0811046","article-title":"A comparison of short- and long-term intravenous antibiotic therapy in the postoperative management of adult osteomyelitis","volume":"81","author":"Swiontkowski","year":"1999","journal-title":"J Bone Joint Surg Br"},{"issue":"4","key":"10.1016\/j.jinf.2015.03.013_bib24","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1128\/AAC.33.4.589","article-title":"Enhanced elimination of ciprofloxacin after multiple-dose administration of rifampin to rabbits","volume":"33","author":"Barriere","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.jinf.2015.03.013_bib25","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1128\/AAC.37.10.2132","article-title":"Influence of rifampin on fleroxacin pharmacokinetics","volume":"37","author":"Schrenzel","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.jinf.2015.03.013_bib26","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1128\/AAC.35.11.2352","article-title":"Crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin alone and in combination in healthy elderly volunteers","volume":"35","author":"Weinstein","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.jinf.2015.03.013_bib27","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1128\/AAC.34.3.442","article-title":"Multiple-dose pharmacokinetics of concurrent oral ciprofloxacin and rifampin therapy in elderly patients","volume":"34","author":"Chandler","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"issue":"11\u201312","key":"10.1016\/j.jinf.2015.03.013_bib28","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3109\/00365548.2011.608082","article-title":"Efficacy of a combined oral clindamycin - rifampicin regimen for therapy of staphylococcal osteoarticular infections","volume":"43","author":"Czekaj","year":"2011","journal-title":"Scand J Infect Dis"},{"issue":"9","key":"10.1016\/j.jinf.2015.03.013_bib29","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1469-0691.2006.01463.x","article-title":"Treatment of acute post-surgical infection of joint arthroplasty","volume":"12","author":"Soriano","year":"2006","journal-title":"Clin Microbiol Infect"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445315001450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445315001450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:21:30Z","timestamp":1759008090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445315001450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0163445315001450"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2015.03.013","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dramatic reduction of clindamycin serum concentration in staphylococcal osteoarticular infection patients treated with the oral clindamycin-rifampicin combination","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2015.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}